celastrol has been researched along with Hodgkin Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdelhay, E; Arce, D; CorrĂȘa, S; Du Rocher, B; Hassan, R; Krsticevic, F; Segges, P; Sternberg, C; Vera-Lozada, G | 1 |
1 other study(ies) available for celastrol and Hodgkin Disease
Article | Year |
---|---|
Targeting Hodgkin and Reed-Sternberg Cells with an Inhibitor of Heat-Shock Protein 90: Molecular Pathways of Response and Potential Mechanisms of Resistance.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Hodgkin Disease; HSP90 Heat-Shock Proteins; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Pentacyclic Triterpenes; Proteome; Proto-Oncogene Mas; ras Proteins; Reed-Sternberg Cells; Triterpenes | 2018 |